top of page
Sat, Oct 01
|Online Event
Transplant Oncology: Immuno-Oncology for Transplant Patients
Solid organ transplant recipients are at 3-10 times higher risk of cancer compared to non-transplant patients, due to long-standing immunosuppression. Cancer immunotherapy has become a standard therapy for many cancers, but its use in transplant patients is challenging because of safety and efficacy
Registration is closed
See other events

bottom of page